Patient and strain characteristics in relation to the outcome of meningococcal disease: a multivariate analysis
- PMID: 8119350
- PMCID: PMC2271487
- DOI: 10.1017/s0950268800057472
Patient and strain characteristics in relation to the outcome of meningococcal disease: a multivariate analysis
Abstract
To investigate the joint association of patient and strain characteristics with the outcome of meningococcal disease (MD), data were collected on 563 consecutive cases of MD reported between 1989 and 1990 in The Netherlands. The meningococcal isolates were characterized with regard to their surface characteristics. Sequelae occurred in 8.5% of the patients, and were only associated with the presence of bacteraemia. The case-fatality rate was 7.7%. Infants aged < or = 5 months and patients in the age-groups of 10-19 years and > or = 50 years had an increased risk for a fatal outcome compared with children from 6 months to 9 years old (Odds Ratios [ORs]: 5.1, 3.4 and 9.8, respectively). The OR for females versus males was 2.3. The ORs for patients with bacteraemia, or a combination of bacteraemia and meningitis, compared with meningitic patients, were 2.3 and 3.1. Meningococcal strain characteristics did not influence the case-fatality rate substantially. In conclusion, host factors were found to be determinants for a fatal outcome of MD in The Netherlands from 1989 to 1990.
Similar articles
-
The case-fatality rate of meningococcal disease in Catalonia, 1990-1997.Scand J Infect Dis. 2004;36(4):274-9. doi: 10.1080/00365540410020163. Scand J Infect Dis. 2004. PMID: 15198184
-
Association of meningococcal serogroups with the course of disease in the Netherlands, 1959-83.Bull World Health Organ. 1987;65(6):861-8. Bull World Health Organ. 1987. PMID: 3124970 Free PMC article.
-
Disease Burden of Invasive Meningococcal Disease in the Netherlands Between June 1999 and June 2011: A Subjective Role for Serogroup and Clonal Complex.Clin Infect Dis. 2015 Oct 15;61(8):1281-92. doi: 10.1093/cid/civ506. Epub 2015 Jun 29. Clin Infect Dis. 2015. PMID: 26123933
-
Meningococci.Crit Rev Microbiol. 1981;8(3):267-302. doi: 10.3109/10408418109085081. Crit Rev Microbiol. 1981. PMID: 6781818 Review. No abstract available.
-
Epidemiology and meningococcal serogroup distribution in the United States.Clin Pediatr (Phila). 2010 Jun;49(6):519-24. doi: 10.1177/0009922809347797. Clin Pediatr (Phila). 2010. PMID: 20507868 Review. No abstract available.
Cited by
-
A meta-analytic evaluation of sex differences in meningococcal disease incidence rates in 10 countries.Epidemiol Infect. 2020 Oct 2;148:e246. doi: 10.1017/S0950268820002356. Epidemiol Infect. 2020. PMID: 33004098 Free PMC article.
-
Cost-utility analysis of a nationwide vaccination programme against serogroup B meningococcal disease in Israel.Int J Public Health. 2016 Jul;61(6):683-692. doi: 10.1007/s00038-016-0821-0. Epub 2016 Apr 22. Int J Public Health. 2016. PMID: 27105884
-
Dynamics of childhood invasive meningococcal disease in Israel during a 22-year period (1989-2010).Infection. 2013 Aug;41(4):791-8. doi: 10.1007/s15010-013-0439-6. Epub 2013 Mar 10. Infection. 2013. PMID: 23475472
-
Bacterial meningitis in children: critical review of current concepts.Drugs. 2005;65(8):1097-112. doi: 10.2165/00003495-200565080-00005. Drugs. 2005. PMID: 15907145 Review.
-
Meningococcal serogroup A, C, W₁₃₅ and Y conjugated vaccine: a cost-effectiveness analysis in the Netherlands.PLoS One. 2013 May 31;8(5):e65036. doi: 10.1371/journal.pone.0065036. Print 2013. PLoS One. 2013. PMID: 23741448 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical